Viral particles which are released after the infection with the human cytomegalovirus, and the use of said particles as a vaccine
US6713070B1 · kind B1 · utility
8Cited by
0References
14Claims
0Family size
Inventor
Key dates
| Filing date | Sep 6, 2001 |
| Grant date | Mar 30, 2004 |
| Priority date | — |
| Expiry date | Sep 6, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16162
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to viral particles which are released by mammal cells after the infection with human cytomegalovirus (HCMV). The invention also relates to particles whose antigenicity has been optimized by changing the HCMV using genetic engineering. The invention further relates to the use of such particles as a vaccine and a method for multiplying the HCMV in mammal cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.